Evert B. Schimmelpennink bought $251K of LENZ Therapeutics (LENZ)

Executed Mar 27, disclosed Mar 30, 3 days later.

Value, as filed

$251K

28,089 sh × $8.95

Executed

Mar 27

the trade date, as filed

Disclosed

Mar 30

3 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

+3.2%

+9.7% from execution

Over the 21 trading sessions from the disclosed entry session (Mar 30), the stock returned +3.2% (delay-adjusted); from the execution session (Mar 27), +9.7%. Derived: entry at the session's open, exit at the close 20 sessions later.

The filer

ES Evert B. Schimmelpennink President, CEO and Secretary profile →

Evert B. Schimmelpennink (President, CEO and Secretary) filed 1 Form 4 report in the trailing twelve months (1 purchase, 0 sales), most often in LENZ. Across 1 priced purchase filing, the average 21-session return was +9.7% from execution and +3.2% from disclosure (delay-adjusted; derived). The largest single filing was $251K of LENZ (28,089 sh × $8.95, as filed), executed Mar 27.

The name

LENZ LENZ LENZ · 11 filings in 24 months ticker → Insider filings, newest first→ View the original filing at www.sec.gov→